TIAA CREF Investment Management LLC lowered its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 15.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 251,398 shares of the real estate investment trust’s stock after selling 44,660 shares during the period. TIAA CREF Investment Management LLC owned about 0.39% of Sabra Healthcare REIT worth $7,022,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares in the last quarter. Bank of Montreal Can increased its stake in Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares in the last quarter. Russell Investments Group Ltd. acquired a new position in shares of Sabra Healthcare REIT during the fourth quarter worth approximately $120,000. Ameritas Investment Partners Inc. acquired a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $156,000. Finally, Stratos Wealth Partners LTD. acquired a new position in shares of Sabra Healthcare REIT during the first quarter worth approximately $207,000. 99.26% of the stock is owned by institutional investors.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) traded up 1.39% during midday trading on Monday, reaching $23.41. 925,904 shares of the company traded hands. The company has a market cap of $1.53 billion, a price-to-earnings ratio of 19.71 and a beta of 0.89. Sabra Healthcare REIT, Inc. has a one year low of $19.30 and a one year high of $29.10.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. Sabra Healthcare REIT had a return on equity of 8.72% and a net margin of 34.99%. The company had revenue of $62.65 million for the quarter, compared to analyst estimates of $63.47 million. During the same period in the prior year, the business earned $0.54 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up .1% compared to the same quarter last year. Equities analysts anticipate that Sabra Healthcare REIT, Inc. will post $1.17 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 17th. Investors of record on Wednesday, August 16th will be issued a dividend of $0.3599 per share. This represents a $1.44 annualized dividend and a dividend yield of 6.15%. The ex-dividend date of this dividend is Monday, August 14th. Sabra Healthcare REIT’s dividend payout ratio is presently 145.76%.

COPYRIGHT VIOLATION WARNING: This story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/07/tiaa-cref-investment-management-llc-lowers-stake-in-sabra-healthcare-reit-inc-nasdaqsbra-updated-updated-updated.html.

A number of brokerages recently commented on SBRA. Zacks Investment Research upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Stifel Nicolaus restated a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. BidaskClub upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Mizuho cut shares of Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $25.00 to $23.00 in a research report on Monday, July 10th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $25.00 price objective (down previously from $28.00) on shares of Sabra Healthcare REIT in a research report on Sunday, July 9th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $26.57.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Stock Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related stocks with our FREE daily email newsletter.